Vente, Kiara .
HRN: 23-47-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/26/2024
01/02/2025
IVTT
300mg
Q6h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes